Ictero Medical is dedicated to pioneering minimally-invasive cryoablation solutions for treating gallstone disease. The company offers a unique approach that provides the benefits of traditional surgery without the associated risks. Ictero Medical's core mission is to develop innovative medical technology that addresses significant clinical needs, focusing on improving patient outcomes with less invasive procedures.
Founded through the Texas Medical Center Biodesign fellowship, Ictero Medical boasts a team of passionate engineers, scientists, clinicians, and entrepreneurs. The company has made significant strides in the medical field by developing its groundbreaking gallbladder ablation solution. This innovation has the potential to transform the treatment landscape for gallstone disease, offering a safer and more effective alternative to conventional surgical methods.
